Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvacta Group Share News (AVCT)

Share Price Information for Avacta Group (AVCT)

Share Price is delayed by 15 minutes
Get Live Data
72.50    2.50 (3.57%)
Bid:
71.00
Ask:
74.00
Spread: 3.00 (4.225%)
Market Cap: £329.95m
AVCT Live PriceLast checked at - London Stock Exchange

Intraday Avacta Group Share Chart

Avacta Group News

Avacta upbeat on evaluation of Covid-19 test strips
24 Jun 2020

Avacta upbeat on evaluation of Covid-19 test strips

(Sharecast News) - Avacta Group announced on Wednesday that the first 'Affimer'-based rapid test strips to detect SARS-CoV-2 (Covid-19) spike protein ...

'No-swab' saliva test for coronavirus piloted in Britain
22 Jun 2020

'No-swab' saliva test for coronavirus piloted in Britain

LONDON, June 22 (Reuters) - A weekly coronavirus testing regime using a "no-swab" saliva test is being trialled in Southampton, southern England, an...

Avacta reports promising findings on potential Covid therapy
18 Jun 2020

Avacta reports promising findings on potential Covid therapy

(Sharecast News) - Avacta Group announced on Thursday that collaborative work with the Centre for Virus Research at the University of Glasgow has show...

UK Shareholder Meetings Calendar - Next 7 Days
15 Jun 2020

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test
9 Jun 2020

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

UK TRADING UPDATE SUMMARY: Omega Wins First Order For Antibody Test

Avacta's Covid-19 test reaches prototype stage
9 Jun 2020

Avacta's Covid-19 test reaches prototype stage

(Sharecast News) - Avacta said its Covid-19 antigen test had reached prototype stage and could detect the virus in model samples.

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies
4 Jun 2020

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Avacta To Raise GBP48 Million To Accelerate Development Of Therapies

Avacta raising £45m to fund diagnostics and therapies pipeline
4 Jun 2020

Avacta raising £45m to fund diagnostics and therapies pipeline

(Sharecast News) - Biotherapeutic and reagent developer Avacta Group announced its intention to raise up to £45m through a placing to institutio...